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Plasma PTX3 levels and serum hs-CRP levels were measured at pre-
PCI. Patients were divided into 2 groups according to the presence
(Group I, n = 34) or absence (Group II, n = 60) of post-PCI TnT
elevation N3 × the upper limit of normal at 24 h after PCI. Result:
Plasma PTX3 (4.06 ± 2.05 ng/ml vs 2.17 ± 1.02 ng/ml, P b 0.001)
and serum hs-CRP levels (0.25 ± 0.03 vs 0.16 ± 0.03, P = 0.048)
were signiﬁcantly higher in Group I than in Group II. Plaque burden
(80.9 ± 5.3 vs 75.4 ± 10.6%, P = 0.047), incidence of positive
remodeling (59 vs 25%, P = 0.034), and percent necrotic core area
(19.0 ± 7.4 vs 14.0 ± 5.9%, P = 0.046) were signiﬁcantly higher in
Group I than in Group II. By ROC analysis, plasma PTX3 levels (AUC
0.823) well discriminated prediction for post-PCI cardiac TnT ele-
vation in comparison with serum hs-CRP levels (AUC 0.618). Best
predictive values of plasma PTX3 levels were 2.83 ng/ml. In the
multiple logistic regression analysis, plasma PTX3 levels were most
independent predictors of post-PCI cardiac TnT elevation. Conclu-
sion: Plasma PTX3 levels may be a useful marker for predicting post-
PCI cardiac TnT elevation, which is associated with the inﬂammatory
status of culprit lesions.
doi:10.1016/j.lfs.2013.12.085
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Background: Suction ﬂow can be visualized with color Doppler
images. However, characteristics of suction ﬂow have never been
quantiﬁed. Vector ﬂow mapping (VFM) can be used to assess intra-
ventricular hemodynamics quantitatively. The purpose of the present
study was to assess the magnitude and timing of suction ﬂow kinetic
energy and to investigate the relationship between left ventricular
(LV) function and geometry in heart failure patients.
Methods: We studied 24 subjects with elevated LV ﬁlling pressure
(eFP group) and 36 normal subjects (normal group) were enrolled.
Suction was deﬁned as the apical ﬂow directing to the apex during the
period from soon after the ejection to before mitral inﬂow. Flow kinetic
energy was quantiﬁed as the sum of the products of blood mass and
velocity vector using VFM. We measured magnitude and time to peak
suction kinetic energy.
Results: Suction was recognized in 12 patients (50%) in the eFP
group and 36 subjects (100%) in the normal group. The eFP group
showed signiﬁcantly smaller suction kinetic energy than the normal
group (2.7 ± 3.8 vs. 5.7 ± 4.4 g/s/cm2, P b 0.01). The eFP group with
suction showed smaller LV end systolic volume (ESV) (P b 0.05), more
ellipsoidal geometry (P b 0.05), and greater untwisting rate (P b 0.01)
than those patients without suction. Regression analysis indicated
a signiﬁcant linear relation between suction kinetic energy and LVEF
(r = 0.48, P b 0.01), eccentricity index (r = 0.27, P = 0.04), and
untwisting rate (r = 0.03, P = 0.04).
Conclusion: Magnitude of the suction ﬂow kinetic energy derived
from VFM may allow quantitative assessment of suction ﬂow,
which correlates to LV systolic function, geometry, and untwisting
mechanics.
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Introduction: Renal denervation (RDN) has been featured as a
novel treatment for hypertension. In animal models of hypertension,
a surgical RDN by cutting nerves with staining phenol has been
reported; however, a radiofrequency (RF) energy has been rarely
applied for RDN. We aimed to evaluate the effects of RF-RDN in
spontaneously hypertensive rats (SHR) and Wistar–Kyoto rats (WKY).
Methods: The RF energy was applied to the bilateral renal arteries by
using a 2 Fr catheter placed through an abdominal incision under
anesthesia in 8 SHR and 8 WKY. The sham operation was performed in
another 8 SHR and 8 WKY. The systolic and diastolic blood pressures
(BP) and urinary norepinephrine secretion were followed up for
3 months after the operations. The RDN was conﬁrmed by a decrease
in renal tissue norepinephrine content as compared to the sham
operation. Results: The RF-RDN in the SHR restrained a spontaneous
rise in systolic BP (46 ± 12% increase from158 ± 8 to 230 ± 14mmHg
vs. 21 ± 18% increase from 165 ± 9 to 197 ± 20mmHg, p = 0.012)
and diastolic BP (55 ± 27% increase from 117 ± 9 to 179 ± 23mmHg
vs. 28 ± 13% increase from 120 ± 7 to 154 ± 13 mmHg, p = 0.035).
The systolic and diastolic BP in the WKY, however, were not affected
by the RF-RDN. Although the RF-RDN did not affect the urinary
norepinephrine secretion, the renal tissue norepinephrine content
was decreased by the RF-RDN in the SHR (302 ± 41 vs. 159 ±
44 ng/g kidney, P b 0.001) and WKY (203 ± 33 vs. 145 ± 26 ng/g
kidney, p = 0.010). Conclusion: The RF-RDN demonstrated an anti-
hypertensive effect with a reduction of renal tissue norepinephrine
content in the SHR.
doi:10.1016/j.lfs.2013.12.087
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We report the case of a 49 year-old woman with pulmonary veno-
occlusive disease (PVOD) who was available to take a vasodilator,
sildenaﬁl, by dose adjustment. In 2001, she complained of dyspnea
on exertion and was diagnosed as idiopathic pulmonary arterial
hypertension; she started receiving beraprost sodium; however, she
discontinued it due to decrease of oxygen partial pressure. Based on
that history and on chest computed tomographic ﬁnding of smoothly
thickened interlobular septa, we diagnosed her with PVOD. In 2005,
bosentanwas administeredwithout any adverse reaction. In November
2012, she complained that dyspnea worsened; she showed the de-
crease of a six-minute walk distance (6 MWD) to 140 m and elevation
of right ventricular systolic pressure (RVSP) estimated by echocardiog-
raphy to 89 mmHg. Sildenaﬁl was initiated from a dose of 20 mg
per day and increased to 40 mg in addition to bosentan without acute
adverse events. Her dyspnea was markedly improved; 6 MWD was
extended to 225 m; and RVSP was diminished to 62 mmHg. When the
dose of sildenaﬁl reached 60 mg, she complained breath shortness
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